Literature DB >> 2886213

Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma.

N C Dracopoli, B Alhadeff, A N Houghton, L J Old.   

Abstract

Restriction fragment length polymorphisms at 61 autosomal and 7 X-linked loci were screened for heterozygosity in cell lines derived from 6 independent metastases and autologous B-cells from a patient with melanoma. Segregations resulting in the loss of heterozygosity were detected in the tumor cells at 8 of 16 autosomes with at least 1 informative locus and at the 3 informative X-linked loci. With a single exception, karyotypic abnormalities were not detected in the region of loci where loss of heterozygosity had been detected. Three patterns of loss were identified: unique segregations in cells from a single metastasis; segregation of the same alleles in different subsets of metastases; and identical segregations in all 6 metastases. The monoclonal derivation of the 6 metastases is supported by the inactivation of the same X-chromosome and the presence of identical segregation at loci on chromosomes 9 and X. Analysis of the patterns of segregation in the metastatic tumor cells permitted the development of a genealogy of tumor progression in this patient and the development of a model of tumor progression which describes the accumulation of selectively neutral and advantageous segregations in metastatic tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886213

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  A genetic linkage map of 27 loci from PND to FY on the short arm of human chromosome I.

Authors:  N C Dracopoli; B Z Stanger; C Y Ito; K M Call; S E Lincoln; E S Lander; D E Housman
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

3.  Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.

Authors:  N C Dracopoli; P Harnett; S J Bale; B Z Stanger; M A Tucker; D E Housman; R F Kefford
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 4.  Genomics screens for metastasis genes.

Authors:  Jinchun Yan; Qihong Huang
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

5.  Confirmation of chromosome 9p linkage in familial melanoma.

Authors:  D J Nancarrow; G J Mann; E A Holland; G J Walker; S C Beaton; M K Walters; C Luxford; J M Palmer; J A Donald; J L Weber
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

6.  Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s).

Authors:  E M Petty; L H Gibson; J W Fountain; J L Bolognia; T L Yang-Feng; D E Housman; A E Bale
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

Review 7.  Genetics of primary intraocular tumors.

Authors:  Nisha Nagarkatti-Gude; Yujuan Wang; Mohammad Javed Ali; Santosh G Honavar; Martine J Jager; Chi-Chao Chan
Journal:  Ocul Immunol Inflamm       Date:  2012-08       Impact factor: 3.070

Review 8.  Antigens of melanocytes and melanoma.

Authors:  S A Lynch; B N Bouchard; S Vijayasaradhi; H Yuasa; A N Houghton
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

9.  Homozygous deletions within human chromosome band 9p21 in melanoma.

Authors:  J W Fountain; M Karayiorgou; M S Ernstoff; J M Kirkwood; D R Vlock; L Titus-Ernstoff; B Bouchard; S Vijayasaradhi; A N Houghton; J Lahti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Familial hypothyroidism caused by a nonsense mutation in the thyroid-stimulating hormone beta-subunit gene.

Authors:  C Dacou-Voutetakis; D M Feltquate; M Drakopoulou; I A Kourides; N C Dracopoli
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.